Contestabile A; Monti B; Polazzi E., Neuronal-glial Interactions Define the Role of Nitric Oxide in Neural Functional Processes, «CURRENT NEUROPHARMACOLOGY», 2012, 10, pp. 303 - 310 [articolo]
Monti B.; Mercatelli D.; Contestabile A., Valproic acid neuroprotection in 6-OHDAlesioned rat, a model for parkinson's disease, «HOAJ BIOLOGY», 2012, 1, pp. 1 - 4 [articolo]
Polazzi E.; Monti B., Microglia and neuroprotection: from in vitro studies to therapeutic applications., «PROGRESS IN NEUROBIOLOGY», 2010, 92 (3), pp. 293 - 315 [articolo]
Monti B.; Gatta V.; Piretti F.; Raffaelli S.; Virgili M.; Contestabile A., Valproic acid is neuroprotective in the rotenone rat model of Parkinson's disease: involvement of alpha synuclein, «NEUROTOXICITY RESEARCH», 2010, 17, pp. 130 - 141 [articolo]
Monti B.; Polazzi E.; Contestabile A., Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection, «CURRENT MOLECULAR PHARMACOLOGY», 2009, 2, pp. 95 - 109 [articolo]
Eleuteri S.; Monti B.; Brignani S.; Contestabile A., Chronic dietary administration of valproic acid protects neurons of the rat nucleus basalis magnocellularis from ibotenic acid neurotoxicity, «NEUROTOXICITY RESEARCH», 2009, 15, pp. 127 - 132 [articolo]
Monti B.; Contestabile A., Memory-enhancing drugs: a molecular perspective, «MINI-REVIEWS IN MEDICINAL CHEMISTRY», 2009, 9, pp. 769 - 781 [articolo]
Polazzi, E.; Pena Altamira, L. E.; Eleuteri, S. C.; Barbaro, M. R.; Casadio, C.; Contestabile, A.; Monti, B., Neuroprotection of microglial conditioned medium on 6-hydroxydopamine-induced neuronal death: role of transforming growth factor beta2, «JOURNAL OF NEUROCHEMISTRY», 2009, 110, pp. 545 - 556 [articolo]
Monti B; Polazzi E; Batti L; Crochemore C; Virgili M; Contestabile A., Alpha-synuclein protects cerebellar granule neurons against 6-hydroxydopamine-induced death., «JOURNAL OF NEUROCHEMISTRY», 2007, 103 (2), pp. 518 - 530 [articolo]
Monti B; D'Alessandro C; Farini V; Bolognesi A; Polazzi E; Contestabile A; Stirpe F; Battelli MG., In vitro and in vivo toxicity of type 2 ribosome-inactivating proteins lanceolin and stenodactylin on glial and neuronal cells., «NEUROTOXICOLOGY», 2007, 28 (3), pp. 637 - 644 [articolo]
Monti B.; Berteotti C:; Contestabile A., Subchronic rolipram delivery activates hippocampal CREB and Arc. enhances retention and slows down extinction of conditioned fear., «NEUROPSYCHOPHARMACOLOGY», 2006, 31, pp. 278 - 286 [articolo]
CROCHEMORE C.; PENA-ALTAMIRA E.; VIRGILI M.; MONTI B.; CONTESTABILE A., Disease-related regressive alterations of forebrain cholinergic system in SOD1 mutant transgenic mice, «NEUROCHEMISTRY INTERNATIONAL», 2005, 46(5), pp. 357 - 368 [articolo]
Monti B.; Berteotti C.; Contestabile A., Dysregulation of memory-related proteins in the hippocampus of aged rats and their relation with cognitive impairment., «HIPPOCAMPUS», 2005, 15, pp. 1041 - 1049 [articolo]
Contestabile A.; Monti B.; Contestabile A.; Ciani E., Updating the dual role of brain nitric oxide in neurodegeneration/neuroprotection: understanding molecular mechanisms to devise drug approaches., in: Frontiers in Medicinal Chemistry, Vol. 2, HILVERSUM, Bentham Science Publishers Ltd., 2005, pp. 63 - 109 (Frontiers in Medicinal Chemistry) [capitolo di libro]
MONTI B.; VIRGILI M.; CONTESTABILE A., Alterations of markers related to synaptic function in aging rat brain, in normal conditions or under conditions of long-term dietary manipulation, «NEUROCHEMISTRY INTERNATIONAL», 2004, 44, pp. 579 - 584 [articolo]
